CSRHub is the world’s largest CSR (corporate social responsibility) and sustainability ratings and information database.

Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of cancer, eye diseases, inflammatory diseases, and pain, and has candidates in preclinical programs for other diseases and disorders. Regeneron has received marketing approval from the U.S. Food and Drug Administration for ARCALYST Injection for Subcutaneous Use for a rare inflammatory condition.